-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DvaLSu96+ZXu8gEOTQquN1+vmRrdZ5ICGylTrpckZ9VAp3s8WffjU3/hTuIU9GrF 47n0wQxCMTHV+cW9xtlTfw== 0000950123-97-008194.txt : 19970930 0000950123-97-008194.hdr.sgml : 19970930 ACCESSION NUMBER: 0000950123-97-008194 CONFORMED SUBMISSION TYPE: SC 14D1/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19970929 SROS: AMEX GROUP MEMBERS: BW ACQUISITION CORPORATION GROUP MEMBERS: CAMBREX CORP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOWHITTAKER INC CENTRAL INDEX KEY: 0000879550 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953917176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-41805 FILM NUMBER: 97687855 BUSINESS ADDRESS: STREET 1: 8830 BIGGS FORD RD CITY: WALKERSVILLE STATE: MD ZIP: 21793 BUSINESS PHONE: 3018987025 MAIL ADDRESS: STREET 1: 8830 BIGGS FORD ROAD CITY: WALKERSVILLE STATE: MD ZIP: 21793 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOWHITTAKER INC CENTRAL INDEX KEY: 0000879550 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953917176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 14D1/A SEC ACT: SEC FILE NUMBER: 005-41805 FILM NUMBER: 97687856 BUSINESS ADDRESS: STREET 1: 8830 BIGGS FORD RD CITY: WALKERSVILLE STATE: MD ZIP: 21793 BUSINESS PHONE: 3018987025 MAIL ADDRESS: STREET 1: 8830 BIGGS FORD ROAD CITY: WALKERSVILLE STATE: MD ZIP: 21793 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D1/A BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D1/A BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 SC 14D1/A 1 AMENDMENT NO. 1 TO SCHEDULE 14D1/SCHEDULE 13D 1 ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------ AMENDMENT NO. 1 SCHEDULE 14D-1 TENDER OFFER STATEMENT PURSUANT TO SECTION 14(d)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AND SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 ------------------------ BIOWHITTAKER, INC. (NAME OF SUBJECT COMPANY (ISSUER)) BW ACQUISITION CORPORATION A WHOLLY-OWNED SUBSIDIARY OF CAMBREX CORPORATION (BIDDER) COMMON STOCK, PAR VALUE $0.01 PER SHARE 09066T 108 (AND ASSOCIATED RIGHTS) (CUSIP NUMBER OF CLASS OF SECURITIES) (TITLE OF CLASS OF SECURITIES)
PETER E. THAUER, ESQ. BW ACQUISITION CORPORATION C/O CAMBREX CORPORATION ONE MEADOWLANDS PLAZA EAST RUTHERFORD, NEW JERSEY 07073 (201) 804-3000 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDER) COPY TO: ANDREW L. SOMMER, ESQ. DEBEVOISE & PLIMPTON 875 THIRD AVENUE NEW YORK, NEW YORK 10022 TELEPHONE: (212) 909-6000 ------------------------ - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 2 - -------------------------- CUSIP NO. 09066T 108 - -------------------------- ----------------------------------------------------------------------------------------------- NAME OF REPORTING PERSON: S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 1 CAMBREX CORPORATION I.R.S. IDENTIFICATION NO. 22-2476135 ----------------------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] 2 (B) [ ] ----------------------------------------------------------------------------------------------- SEC USE ONLY 3 ----------------------------------------------------------------------------------------------- SOURCES OF FUNDS (SEE INSTRUCTIONS) 4 BK ----------------------------------------------------------------------------------------------- CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 5 PURSUANT TO ITEMS 2(E) OR 2(F) [ ] ----------------------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 6 DELAWARE ----------------------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7 10,128,479 SHARES ----------------------------------------------------------------------------------------------- CHECK IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN 8 SHARES (SEE INSTRUCTIONS) [ ] ----------------------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) 9 93.1% ----------------------------------------------------------------------------------------------- TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 10 CO -----------------------------------------------------------------------------------------------
3 - -------------------------- CUSIP NO. 09066T 108 - -------------------------- ----------------------------------------------------------------------------------------------- NAME OF REPORTING PERSON: S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 1 BW ACQUISITION CORPORATION I.R.S. IDENTIFICATION NO. APPLIED FOR ----------------------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) [ ] 2 (B) [ ] ----------------------------------------------------------------------------------------------- SEC USE ONLY 3 ----------------------------------------------------------------------------------------------- SOURCES OF FUNDS (SEE INSTRUCTIONS) 4 BK ----------------------------------------------------------------------------------------------- CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 5 PURSUANT TO ITEMS 2(E) OR 2(F) [ ] ----------------------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 6 DELAWARE ----------------------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7 10,128,479 ----------------------------------------------------------------------------------------------- CHECK IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN 8 SHARES (SEE INSTRUCTIONS) [ ] ----------------------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) 9 93.1% ----------------------------------------------------------------------------------------------- TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 10 CO -----------------------------------------------------------------------------------------------
4 BW Acquisition Corporation ('Purchaser') hereby amends and supplements its Tender Offer Statement on Schedule 14D-1 (the "Statement"), originally filed on August 28, 1997 with respect to its offer to purchase all outstanding shares of common stock, par value $0.01 per share, of BioWhittaker, Inc. (the "Company"), a Delaware corporation, and associated rights to purchase Series A Cumulative Preferred Stock, par value $0.01 per share (together with the common stock, the "Shares"), at a price of $11.625 per Share, net to the seller in cash. ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY. Item 6 of this Statement is hereby amended and supplemented as follows: The Offer expired at 12:00 Midnight, New York City time, on Thursday, September 25, 1997. According to the Depositary, based on a preliminary count, there were validly tendered and not properly withdrawn approximately 10,128,479 Shares (including 166,514 Shares tendered by means of a Notice of Guaranteed Delivery) as of the Expiration Date, representing approximately 93.1% of the Shares currently outstanding. The Purchaser accepted for payment all Shares validly tendered in accordance with the Offer. On September 25, 1997, Cambrex Corporation issued a press release, a copy of which is attached hereto as Exhibit 11(a)(9) and is incorporated herein by reference. ITEM 11. MATERIAL TO BE FILED AS EXHIBITS. Item 11 of this Schedule 14D-1 is hereby amended and supplemented by adding the following text thereafter. (11)(a)(9) Press Release issued by Cambrex Corporation on September 25, 1997. 5 SIGNATURE After due inquiry and to the best of our knowledge and belief, we certify that the information set forth in this Statement is true, complete and correct. BW ACQUISITION CORPORATION By: /s/ PETER E. THAUER ------------------------------------ Name: Peter E. Thauer Title: Vice President CAMBREX CORPORATION By: /s/ PETER E. THAUER ------------------------------------ Name: Peter E. Thauer Title: Vice President Date: September 29, 1997 2 6 EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION PAGE NO. - -------- ------------------------------------------------------------------------ -------- 11(a)(1)* Offer to Purchase dated August 28, 1997................................. 11(a)(2)* Letter of Transmittal................................................... 11(a)(3)* Notice of Guaranteed Delivery........................................... 11(a)(4)* Letter from the Dealer Manager to Brokers, Dealers, Commercial Banks, Trust Companies and Nominees............................................ 11(a)(5)* Letter to clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Nominees.................................................. 11(a)(6)* Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9..................................................... 11(a)(7)* Summary Advertisement as published on August 28, 1997................... 11(a)(8)* Joint Press Release issued by Parent and the Company on August 25, 1997.................................................................... 11(a)(9) Press release issued by Cambrex Corporation on September 25, 1997....... 11(b)(1)* Commitment Letter, dated as of August 20, 1997, as amended, by and among Parent and the financial institutions listed therein.................... 11(c)(1)* Agreement and Plan of Merger, dated as of August 22, 1997, among Parent, the Purchaser and the Company. 11(c)(2)* Stockholders Agreement, dated as of August 22, 1997, between Parent and Anasco GmbH............................................................. 11(c)(3)* Management Stockholders Agreement, dated as of August 22, 1997, among Parent and the stockholders named therein............................... 11(c)(4)* Form of Employment Letter dated, August 22, 1997, among Parent, the Purchaser and certain executives of the Company. 11(c)(5)* Form of Employment Letter, dated August 22, 1997, among Parent, the Purchaser and Noel L. Buterbaugh. 11(c)(6)* Form of Assumption Agreement, dated as of August 22, 1997, among Parent, the Purchaser and the Company.
- --------------- * As previously filed EX-99.11.A.9 2 PRESS RELEASE 1 Exhibit 11(a)(9) [CAMBREX LETTERHEAD] NEWS RELEASE Release Date: September 25, 1997 Contact: Douglas H. MacMillian Vice President/CFO 201-804-3025 CAMBREX CASH TENDER OFFER FOR BIOWHITTAKER SUCCEEDS: 93% OF SHARES SUPPORT CAMBREX OFFER East Rutherford, New Jersey, September 26, 1997 - Cambrex Corporation (AMEX:CMB) announced today that the tender offer for shares of BioWhittaker, Inc. (NYSE:BWI) at $11.625 per share expired as scheduled at 12:00 midnight New York City Time, on September 25, 1997. The offer by BW Acquisition Corporation, a wholly-owned subsidiary of Cambrex, was for all of the outstanding shares of common stock, par value $0.01 per share, of BioWhittaker. The Depository for the Offer informed Cambrex that 10,128,479 shares (including shares tendered through guaranteed delivery procedures) were validly tendered and not withdrawn. BW Acquisition Corporation has accepted all shares validly tendered for purchase. After giving effect to the purchase of such tendered shares, BW Acquisition Corporation will own 93% (assuming the valid tender of shares tendered pursuant to guaranteed delivery procedures) of the 10,881,210 shares outstanding as of the expiration of the Offer. Cambrex also announced that BW Acquisition Corporation intends to merge with and into BioWhittaker pursuant to the short form merger provisions of the Delaware General Corporation Law. As a result of the merger, BioWhittaker would become a wholly-owned subsidiary of Cambrex and all remaining BioWhittaker shareholders (other than Cambrex and its affiliates) would be entitled to receive the same $11.625 cash price for each of their shares. "We are pleased with the strong response to our offer and welcome BioWhittaker and its more than 400 employees to the Cambrex family of companies," said Jim Mack, Cambrex CEO. "BioWhittaker's growth prospects for products used in biopharmaceutical manufacture are very exciting and enhance our ability to meet our strategic goals in 1998 and beyond." -----END PRIVACY-ENHANCED MESSAGE-----